Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Mukherjee

Showing results (171-180 of 174) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 174 results.
Mutation Research|June 1, 1983
Effect of low-dose acute X-irradiation on the frequencies of chromosomal aberrations in human peripheral lymphocytes in vitroJ Pohl-Rüling, P Fischer, O Haas, et al.
The Journal of Antimicrobial Chemotherapy|December 17, 2019
In vitro activity of a novel antibacterial agent, levonadifloxacin, against clinical isolates collected in a prospective, multicentre surveillance study in India during 2016-18Boppe Appalaraju, Sujata Baveja, Shrikala Baliga, et al.
Mutation Research|October 1, 1982
Evaluation of radiation-induced chromosomal aberrations in human peripheral blood lymphocytes in vitro: result of an IAEA-coordinated programmeM Bianchi, N O Bianchi, J G Brewen, et al.
Indian Journal of Medical Microbiology|December 12, 2022
India-discovered levonadifloxacin & alalevonadifloxacin: A review on susceptibility testing methods, CLSI quality control and breakpoints along with a brief account of their emerging therapeutic profile as a novel standard-of-careBalaji Veeraraghavan, Yamuna Devi Bakthavatchalam, Abi Manesh, et al.
Pageof 18

Showing results (171-180 of 174) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 174 results.
Mutation Research|June 1, 1983
Effect of low-dose acute X-irradiation on the frequencies of chromosomal aberrations in human peripheral lymphocytes in vitroJ Pohl-Rüling, P Fischer, O Haas, et al.
The Journal of Antimicrobial Chemotherapy|December 17, 2019
In vitro activity of a novel antibacterial agent, levonadifloxacin, against clinical isolates collected in a prospective, multicentre surveillance study in India during 2016-18Boppe Appalaraju, Sujata Baveja, Shrikala Baliga, et al.
Mutation Research|October 1, 1982
Evaluation of radiation-induced chromosomal aberrations in human peripheral blood lymphocytes in vitro: result of an IAEA-coordinated programmeM Bianchi, N O Bianchi, J G Brewen, et al.
Indian Journal of Medical Microbiology|December 12, 2022
India-discovered levonadifloxacin & alalevonadifloxacin: A review on susceptibility testing methods, CLSI quality control and breakpoints along with a brief account of their emerging therapeutic profile as a novel standard-of-careBalaji Veeraraghavan, Yamuna Devi Bakthavatchalam, Abi Manesh, et al.
Pageof 18